TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | -1 | 0 | 21 | 41 | 60 | 9 | 26 |
| P | %wins | 67 | 67 | 33 | 100 | 100 | 100 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/17 17:26 | 5/12/17 | COLL | Collegium Pharmaceutical, Inc | VA | Health | Drug | Pharmaceutical Preparations | Brannelly Paul | MA | O | EVP,CFO | P | 92 | 9.18 | 4 | 10 | 10 | 110 | D | -29 | -37 | -42 | -38 | -6 | -7 | 7 | 15 | ||||||
5/15/14 16:42 | 5/15/14 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brannelly Paul | MA | O | SVP,FINA | P | 18 | 25.95 | 5 | 1 | 1 | 66 | D | 66 | -25 | -17 | -3 | -8 | 0 | 0 | 1 | 79 | 42 | 64 | 3 | ||
5/14/14 16:02 | 5/14/14 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brannelly Paul | MA | O | SVP,FINA | P | 22 | 26.93 | 6 | 1 | 1 | 65 | D | 62 | -24 | -17 | -6 | -1 | 2 | -3 | -2 | -9 | 41 | 61 | 10 | ||
5/13/14 17:10 | 5/13/14 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brannelly Paul | MA | O | SVP,FINA | P | 28 | 28.06 | 6 | 1 | 2 | 65 | D | 75 | -17 | -9 | -1 | 5 | 6 | 1 | 1 | -6 | 40 | 56 | 14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |